Stock Taper Revenues: Increased by 15% to approximately $732.1 million, up from $636.2 million in Q2 2025.
Net Income: Rose 63% to approximately $47.5 million ($0.36 per diluted share), compared to $29.1 million ($0.21 per diluted share) in the prior year.
Adjusted EBITDA: Increased by 20% to approximately $142 million, up from $118.6 million in Q2 2025.
Operating Expenses: Grew by 12% due to increased occupancy and activation of ICE facility contracts.
Debt: Total debt stood at approximately $1.54 billion, with net leverage below 3x adjusted EBITDA.
Contract Wins: GEO secured several new contracts in 2025, projected to generate approximately $520 million in annual revenues, marking the largest single-year contract wins in company history.
ICE Facilities: New contracts to house ICE detainees at four facilities valued at approximately $280 million annually, increasing active ICE beds to approximately 27,000.
ISAP-V Program: Continued growth in the use of higher-priced monitoring devices, with participants on GPS ankle monitors increasing from 17,000 to 54,000 since early 2025.
Facility Reactivation: Announced contracts for reactivating two previously idle facilities (Bighorn and Rivers) expected to generate approximately $165 million in annual revenues once operational by early 2027.
2026 Guidance: Increased net income guidance to $168 million - $175 million and adjusted EBITDA guidance to $550 million - $560 million.
Q3 and Q4 2026 Expectations: Q3 GAAP net income projected at $45 million - $48 million; Q4 GAAP net income expected at $37 million - $41 million.
Capital Expenditures: Anticipated unreimbursed CapEx for 2026 between $135 million and $145 million, with expectations to decline below $100 million in 2027.
Delay in Florida Facilities: Two contracts originally set to start in July 2026 have been pushed to July 2027 due to unresolved budgetary issues, affecting revenue expectations.
Skip Tracing Contract: No revenues were realized in Q2 due to a lapse in ICE funding, although there is optimism for ramp-up in the second half of 2026.
ISAP Program Stability: While there is a positive trend in technology and case management shifts, overall participation in the ISAP program has been flat, raising concerns about future growth potential.
Focus on Detention Capacity: Management indicated that ICE's current priority is on increasing detention capacity rather than expanding the ISAP program, which may limit growth in that area.
Potential Facility Sales: Discussions regarding the sale of GEO facilities to ICE are ongoing, with management expressing that proceeds would be used for debt reduction and shareholder returns.
Monitoring Services for Immigrants: There is potential for increased ISAP program participation due to new policies affecting Haitian immigrants, which could shift focus back to monitoring services.
Capital Allocation Post-Sales: Management indicated that proceeds from potential asset sales would likely be split between debt repayment and shareholder returns, emphasizing a commitment to enhancing shareholder value. This summary encapsulates the key points from GEO Group's Q2 2026 earnings call, providing a balanced view of their financial performance, strategic initiatives, and outlook while highlighting areas of concern.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT